首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2375362篇
  免费   198564篇
  国内免费   4209篇
耳鼻咽喉   34337篇
儿科学   72854篇
妇产科学   63034篇
基础医学   335400篇
口腔科学   67653篇
临床医学   215945篇
内科学   469227篇
皮肤病学   48067篇
神经病学   201059篇
特种医学   96065篇
外国民族医学   886篇
外科学   360827篇
综合类   56255篇
现状与发展   1篇
一般理论   979篇
预防医学   191068篇
眼科学   55576篇
药学   177845篇
  4篇
中国医学   4372篇
肿瘤学   126681篇
  2018年   24289篇
  2016年   20672篇
  2015年   23364篇
  2014年   33643篇
  2013年   50965篇
  2012年   68934篇
  2011年   72446篇
  2010年   42593篇
  2009年   40976篇
  2008年   68931篇
  2007年   73303篇
  2006年   74192篇
  2005年   72226篇
  2004年   69507篇
  2003年   67169篇
  2002年   66405篇
  2001年   112528篇
  2000年   116615篇
  1999年   98420篇
  1998年   27912篇
  1997年   25572篇
  1996年   25481篇
  1995年   24651篇
  1994年   23197篇
  1993年   21589篇
  1992年   79437篇
  1991年   76469篇
  1990年   73658篇
  1989年   70908篇
  1988年   65923篇
  1987年   64868篇
  1986年   61394篇
  1985年   58456篇
  1984年   44277篇
  1983年   37696篇
  1982年   22917篇
  1981年   20365篇
  1980年   19055篇
  1979年   41335篇
  1978年   29012篇
  1977年   24373篇
  1976年   22861篇
  1975年   23998篇
  1974年   29673篇
  1973年   28083篇
  1972年   26249篇
  1971年   24173篇
  1970年   22774篇
  1969年   21108篇
  1968年   19150篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
42.
43.
44.
45.
46.
47.
48.
Acne vulgaris (acne) is a chronic inflammatory disease of the sebaceous gland, characterized by follicular hyperkeratinization, excessive colonization by Propionibacterium acnes (Pacnes) as well as immune reactions and inflammation. Despite an armamentarium of topical treatments available including benzoyl peroxide, retinoids and azelaic acid, topical antibiotics in monotherapies, especially erythromycin and clindamycin, are still used in Europe to treat acne. This intensive use led to antimicrobial‐resistant P. acnes and staphylococci strains becoming one of the main health issues worldwide. This is an update on the current topical acne treatments available in Europe, their mechanism of action, their potential to induce antimicrobial resistance and their clinical efficacy and safety.  相似文献   
49.
50.
Dosage form is a mean used for the delivery of drug to a living body. In order to get the desired effect the drug should be delivered to its site of action at such rate and concentration to achieve the maximum therapeutic effect and minimum adverse effect. Since oral route is still widely accepted route but having a common drawback of difficulty in swallowing of tablets and capsules. Therefore a lot of research has been done on novel drug delivery systems. This review is about oral dispersible tablets a novel approach in drug delivery systems that are now a day''s more focused in formulation world, and laid a new path that, helped the patients to build their compliance level with the therapy, also reduced the cost and ease the administration especially in case of pediatrics and geriatrics. Quick absorption, rapid onset of action and reduction in drug loss properties are the basic advantages of this dosage form.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号